Risk Factors Update Summary
- Reimbursement rates for clinical laboratory tests under Medicare were reduced during 2018-2020. This remains a catalyst for change. This reduction is capped at 15% annually from 2025-2027.
- Delay in the next data collection and reporting period until January 1, 2025, due to federal legislation. This further delayed reimbursement rate reductions and reporting requirements.
- Proposed legislation aims to reform PAMA, creating a true market-based Clinical Laboratory Fee Schedule. This could impact the company's operations significantly.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1022079&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.